Clinical Research Directory
Browse clinical research sites, groups, and studies.
U-LABA/ICS Effects on Exercise Performance, Indacaterol
Sponsor: Morten Hostrup, PhD
Summary
The purpose of the project is to investigate exercise performance in humans following bronchodilation induced by acute inhalation of beta2-agonist indacaterol + mometasonefuroate
Official title: Physiological Response to U-LABA/ICS With Emphasis on Exercise Performance, Indacaterol
Key Details
Gender
All
Age Range
18 Years - 39 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-01-15
Completion Date
2026-12-01
Last Updated
2025-04-09
Healthy Volunteers
Yes
Conditions
Interventions
Indacaterol and Mometasonefluroate (low dose)
Participants are administered 125 µg indacaterol + mometasonefluroate
Placebo
Participants are administered placebo
Indacaterol and Mometasonefluroate (high dose)
Participants are administered 500 µg indacaterol + mometasonefluroate
Locations (1)
August Krogh Building
Copenhagen, Denmark